CMS' rule ending Medicaid and CHIP funding for pediatric sex-rejecting procedures is now in effect.
|Articles|October 1, 2000
Supplements and Featured Publications
- Optimizing the Management of Gastroesophageal Reflux Disease and its Complications
- Volume 6
- Issue 16 Suppl
Maximizing Outcome of Extraesophageal Reflux Disease
Author(s)Peter J. Kahrilas, MD
Advertisement
Articles in this issue
about 26 years ago
Participating Facultyabout 26 years ago
Introductionabout 26 years ago
Managed Care Issues in the Treatment of Gastroesophageal Reflux Diseaseabout 26 years ago
Changes in the Hypopharynx May Suggest Supraesophageal Reflux Diseaseabout 26 years ago
Diagnosing and Managing Barrett's Esophagusabout 26 years ago
Guidelines for Managing Short-Segment Barrett's Esophagusabout 26 years ago
Total Acid Suppression and Its Effect on Barrett's Esophagusabout 26 years ago
Ablative Therapies for Barrett's Esophagusabout 26 years ago
Selected AbstractsAdvertisement
Related to this article
At a roundtable in Cleveland, kidney experts said IgA nephropathy and FSGS often go unrecognized, calling for EHR flags and better referral channels.
Labial gland biopsy may support diagnosis of neurologic Sjögren disease, especially when antibody tests are negative or inconclusive.
This analysis in RR MCL shows CAR T-cell therapy (brexucabtagene) yields higher complete responses vs bispecific antibodies; durability remains unclear.
Meta-analysis finds oral JAK inhibitors like baricitinib and ritlecitinib drive strong alopecia areata hair regrowth, improving SALT scores with manageable safety.
Follitropin delta yields cumulative ongoing pregnancy in 64.0% of patients under 35 and 43.9% of those 35 to 42 in 2 placebo-controlled IVF trials.
The Ambulatory Specialty Model aims to reduce chronic disease costs by mandating specialist participation and tying payments to quality and cost, while posing nationwide risk challenges.
Medicare drug price negotiations lowered out-of-pocket costs for some beneficiaries, but those reaching the annual Part D cap saw no direct savings.
Advertisement
Advertisement
Trending on AJMC
1
Medicare Drug Price Negotiations Yield Uneven Out-of-Pocket Savings
2
Rusfertide Keeps Working Where Hydroxyurea Fades: Andrew Kuykendall, MD
3
Lymphoma Outcomes Hinge on Oncology, Not Viral Load In People With HIV
4
Consensus Helps Dermatologists Spot CTCL Mimicking Atopic Dermatitis on Dupilumab
5